Gabinet Lekarski Bartosz Korczowski — Clinical Trial Site

10 Registered trials

3 Currently recruiting

Organisation

Gabinet Lekarski Bartosz Korczowski

Location

Rzeszów, Poland

Identifier

ORL-000000296

Address

ul. Litewska 4A/7, 35-302, Poland

Departments

-
.
Gastroenterology
N/A

Clinical trials at this site (10)

Search interface

A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis Recruiting

2024-511458-32-00 Ulcerative colitis 5 2025-06-15
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease ( ENHANCE-CD ) Recruiting

2023-508234-34-00 Crohn's disease 4 2025-01-27
Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants with Moderately to Severely Active Crohn’s Disease Recruiting

2023-504735-41-00 Moderately to Severely Active Crohn's Disease 5 2024-03-05
A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Sub… Ended

2022-501349-64-00 Symptomatic nonerosive GERD in paediatric subjects aged 4 2026-01-12
A Study of Mirikizumab (LY3074828) in Pediatric Participants with Crohn’s Disease (AMAY) Ended

2024-511472-32-00 Crohn's Disease 5 2024-03-12
A Phase 2, Double-Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of EE and Maintenance of Healed EE in Pediatric… Ended

2022-501350-11-00 Erosive Esophagitis 4 2026-04-09
A Study to Investigate Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age with Moder… Ended

2022-502183-20-00 Moderately to Severely Active Ulcerative Colitis 5 2024-02-26
ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Ended

2022-500536-11-01 Moderately to severely active ulcerative colitis 5 2023-06-08
A Phase 3 Study to Evaluate the Efficacy and Safety of Darvadstrocel in the Treatment of Complex Perianal Fistula in Pediatric Subjects with… Ended

2023-503973-39-00 Complex Perianal Fistulas in Crohn's Disease 5 2021-03-16
A Multi-Center, Open-Label Study of Adalimumab to Evaluate Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Ped… Ended

2023-504711-32-00 Ulcerative Colitis 5 2015-11-24